which glp-1 has less side effects Survey: 37.5% of People Stop GLP-1s after Just 3 Months Which GLP-1 medication is most

Schedule: Daily subcutaneous injections for 812 weeks, optionally extended to ~16 weeks for advanced protocols

Neither route is automatically better for everyone

Innovators must rely on the Doctrine of Equivalents, which is subject to legal defenses such as prosecution history estoppel (if the patentee narrowed their claims during the application process to exclude salts, they cannot reclaim them now)

Emerging research shows improvement in liver enzymes and reduced liver fat, but they are not yet approved for NAFLD treatment

Lilly and competitor Novo Nordisk (NVO) are the duopoly controlling the current GLP-1 market, and there is more demand than the companies combined can supply